|
ACP1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.880430E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.379600E-01 |
| Normal-vs-Stage2 |
7.669000E-01 |
| Normal-vs-Stage3 |
1.582280E-02 |
| Normal-vs-Stage4 |
8.783600E-03 |
| Stage1-vs-Stage2 |
8.922800E-01 |
| Stage1-vs-Stage3 |
7.460000E-03 |
| Stage1-vs-Stage4 |
3.915900E-03 |
| Stage2-vs-Stage3 |
6.896100E-02 |
| Stage2-vs-Stage4 |
5.843600E-02 |
| Stage3-vs-Stage4 |
8.553600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.430600E-01 |
| Normal-vs-AfricanAmerican |
6.982100E-02 |
| Normal-vs-Asian |
9.527600E-01 |
| Caucasian-vs-AfricanAmerican |
2.859600E-01 |
| Caucasian-vs-Asian |
7.612400E-01 |
| AfricanAmerican-vs-Asian |
4.380600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.717500E-02 |
| Normal-vs-Female |
9.930200E-01 |
| Male-vs-Female |
9.703700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.979900E-02 |
| Normal-vs-Age(41-60Yrs) |
2.332800E-01 |
| Normal-vs-Age(61-80Yrs) |
5.369800E-01 |
| Normal-vs-Age(81-100Yrs) |
2.912800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.556400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.007200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.687400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.032600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.934600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.798800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.227200E-01 |
| Normal-vs-Grade 2 |
2.455000E-01 |
| Normal-vs-Grade 3 |
9.414300E-02 |
| Normal-vs-Grade 4 |
2.50719999994597E-06 |
| Grade 1-vs-Grade 2 |
7.984600E-01 |
| Grade 1-vs-Grade 3 |
6.175900E-02 |
| Grade 1-vs-Grade 4 |
1.644950E-04 |
| Grade 2-vs-Grade 3 |
8.435700E-03 |
| Grade 2-vs-Grade 4 |
3.41629999955906E-07 |
| Grade 3-vs-Grade 4 |
8.766800E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.554000E-04 |
| Normal-vs-ccB subtype |
3.1725000000371E-06 |
| ccA subtype-vs-ccB subtype |
4.55191440096314E-14 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.197800E-01 |
| Normal-vs-N1 |
6.900000E-02 |
| N0-vs-N1 |
2.031200E-01 |
|
|
